The cancer biopsy market share is a crucial aspect of the healthcare industry, as it provides valuable insights into the prevalence and distribution of various types of cancers. Biopsy procedures play a pivotal role in diagnosing cancer, determining its stage, and guiding treatment decisions. Understanding the market share helps stakeholders identify trends, develop effective strategies, and allocate resources appropriately.

Currently, the cancer biopsy market is witnessing significant growth due to several factors. Firstly, the rising incidence of cancer globally has led to an increased demand for accurate and reliable diagnostic techniques. As more people are being diagnosed with different types of cancers, there is a greater need for efficient biopsy procedures to confirm the presence of malignancy.

Additionally, advancements in technology have revolutionized the field of cancer diagnostics. The introduction of minimally invasive techniques such as liquid biopsies and image-guided biopsies has improved patient comfort and reduced procedural risks. These innovative approaches have gained popularity among both patients and healthcare providers, contributing to the expansion of the biopsy market.

Furthermore Moreover, the integration of artificial intelligence and machine learning algorithms in cancer diagnostics has shown promising results in terms of accuracy and efficiency, paving the way for more personalized and effective treatment options.

The Cancer Biopsy Market Size was valued at USD 26.24 billion in 2022, and is expected to reach USD 61.06 billion by 2030 and grow at a CAGR of 11.13% over the forecast period 2023-2030.

Get Free Sample Report @


By Product

  • Kits and Consumables
  • Instruments
  • Services

By Type

  • Tissue Biopsies
  • Surgical Biopsies
  • Liquid Biopsies
  • Core Needle Biopsy (CNB)
  • Needle Biopsies
  • Fine Needle Aspiration (FNA)
  • Others

By Application

  • Breast Cancer
  • Prostate Cancers
  • Cervical Cancers
  • Colorectal Cancer
  • Pancreatic Cancers
  • Lung Cancers
  • Kidney Cancers
  • Blood Cancers
  • Ovarian Cancers
  • Skin Cancers
  • Liver Cancers

Some of the major key players are as follows: ANGLE Plc, BD (Becton, Dickinson and Company), Biocept, Inc., Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Myriad Genetics, Qiagen N.V., Thermo Fisher Scientific, Inc, and other players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),